1. Home
  2. CRDL vs BCBP Comparison

CRDL vs BCBP Comparison

Compare CRDL & BCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDL
  • BCBP
  • Stock Information
  • Founded
  • CRDL 2017
  • BCBP 2000
  • Country
  • CRDL Canada
  • BCBP United States
  • Employees
  • CRDL N/A
  • BCBP N/A
  • Industry
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • BCBP Savings Institutions
  • Sector
  • CRDL Health Care
  • BCBP Finance
  • Exchange
  • CRDL Nasdaq
  • BCBP Nasdaq
  • Market Cap
  • CRDL 126.5M
  • BCBP 143.5M
  • IPO Year
  • CRDL N/A
  • BCBP N/A
  • Fundamental
  • Price
  • CRDL $1.05
  • BCBP $8.78
  • Analyst Decision
  • CRDL Strong Buy
  • BCBP Hold
  • Analyst Count
  • CRDL 2
  • BCBP 2
  • Target Price
  • CRDL $9.00
  • BCBP $9.50
  • AVG Volume (30 Days)
  • CRDL 1.2M
  • BCBP 58.0K
  • Earning Date
  • CRDL 08-14-2025
  • BCBP 10-17-2025
  • Dividend Yield
  • CRDL N/A
  • BCBP 7.32%
  • EPS Growth
  • CRDL N/A
  • BCBP N/A
  • EPS
  • CRDL N/A
  • BCBP 0.19
  • Revenue
  • CRDL N/A
  • BCBP $65,498,000.00
  • Revenue This Year
  • CRDL N/A
  • BCBP $22.81
  • Revenue Next Year
  • CRDL N/A
  • BCBP $8.60
  • P/E Ratio
  • CRDL N/A
  • BCBP $45.75
  • Revenue Growth
  • CRDL N/A
  • BCBP N/A
  • 52 Week Low
  • CRDL $0.77
  • BCBP $7.54
  • 52 Week High
  • CRDL $2.63
  • BCBP $14.04
  • Technical
  • Relative Strength Index (RSI)
  • CRDL 39.49
  • BCBP 51.66
  • Support Level
  • CRDL $1.12
  • BCBP $8.62
  • Resistance Level
  • CRDL $1.14
  • BCBP $9.27
  • Average True Range (ATR)
  • CRDL 0.07
  • BCBP 0.20
  • MACD
  • CRDL -0.00
  • BCBP -0.01
  • Stochastic Oscillator
  • CRDL 5.56
  • BCBP 34.67

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

Share on Social Networks: